Pharma Pulse: Cholesterol Imbalance Tied to Depression Risk, Lilly Acquires Aderum Biotechnologies, and Cambrex Expands API Manufacturing | Pharmaceutical Commerce

Pharma Pulse: Cholesterol Imbalance Tied to Depression Risk, Lilly Acquires Aderum Biotechnologies, and Cambrex Expands API Manufacturing | Pharmaceutical Commerce

2025-10-27 — Pharmaceutical Commerce

Pharma Pulse: Latest Developments Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & t…


Disruptive Innovation in MedTech: Rethinking the Future of Healthcare - TCT 2025 Update

Disruptive Innovation in MedTech: Rethinking the Future of Healthcare - TCT 2025 Update

2025-10-27 — Medical Dialogues

Disruptive Innovation in MedTech: Rethinking the Future of Healthcare - TCT 2025 Update The Medical Dialogues Bureau covers the news from …

How artist-designed shade structures are protecting vulnerable residents in US’s hottest city

How artist-designed shade structures are protecting vulnerable residents in US’s hottest city

2025-10-27 — The Art Newspaper

Artist-Designed Shade Structures in Phoenix, Arizona The city of Phoenix, Arizona, the hottest city in the US, is combating rising tempera…

Agencies and buyers need guard rails to protect CTV ad buying

Agencies and buyers need guard rails to protect CTV ad buying

2025-10-27 — The Media Online

CTV Ad Buying: A Murky World Agencies and buyers need protection when it comes to connected TV (CTV) ad buying, as the industry is filled …

Microsoft facing huge lawsuit involving millions of citizens over unfair software pricing - here's what we know

Microsoft facing huge lawsuit involving millions of citizens over unfair software pricing - here's what we know

2025-10-27 — TechRadar

Microsoft Facing Lawsuit Over Unfair Software Pricing Microsoft is being sued by the Australian Competition & Consumer Commission (ACCC) f…

© 2025 narangian.org News Aggregator
About Us · Privacy Policy · Terms of Service · DMCA Notice